Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from CME Group

Federal Reserves Faces The Challenges Of A Tricky Balancing Act

Back in March 2022, the Federal Reserve embarked on an unprecedented interest rate hiking cycle

Zenger

Your 2022 picks: Our top 10 LPGA golf stories (No. 1 is an idea that could get Nelly Korda to the Presidents Cup)

Here’s a look at the top 10 LPGA stories, as clicked on by you.

USA Today Sports Media Group

‘I said you’re a fraud.’ CME Group’s boss spotted early trouble at crypto exchange FTX

Terrence Duffy, chairman of Chicago-based exchange owner CME Group, said his meeting with Sam Bankman-Fried showed FTX had no plan to prevent trading calamities that could have spread across the financial system.

Chicago Sun-Times

From analysis to the latest developments in health,
read the most diverse news in one place.

CME Group CEO ‘exceptionally disappointed’ with LPGA leadership heading into record payday

“I’m concerned about the future of the tour," said Duffy, who will hand over a $2 million check on Sunday.

USA Today Sports Media Group

Photos: 2022 CME Group Tour Championship at Tiburon Golf Club

The tournament features a $2 million first-place prize, the highest on the LPGA.

USA Today Sports Media Group

$4 Million Bet On Boeing? Check Out 4 Stocks Insiders Are Buying

Although US stocks closed higher on Tuesday, there were a few notable insider trades.

Benzinga

Dogecoin Sprints Higher, Even As Bitcoin, Ethereum Lag — But Metric Signals Party Could Be Over Soon For Meme Coin

Bitcoin was largely flat, while Dogecoin and Ethereum registered gains on Tuesday evening as the global cryptocurrency market cap remained mostly unchanged at $1 trillion at 9:01 p.m. EDT.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022

Upgrades

Benzinga

CME Group Files For Futures Brokerage After Criticizing Rival FTX For Doing The Same Thing

After criticizing cryptocurrency exchange FTX for its plans to cut out the middlemen in the futures markets, CME Group Inc.

Benzinga

CME Group has investment ideas for the masses

The owner of Chicago’s futures markets has rolled out event contracts tied to leading market statistics.

Chicago Sun-Times

Benzinga's Top Ratings Upgrades, Downgrades For August 17, 2022

Benzinga

Insider Selling This Stock Ahead Of Earnings; Also Check Out These 3 Other Stocks Insiders Are Selling

The Nasdaq index closed lower on Tuesday amid a decline in tech stocks. Investors, meanwhile, focused on some notable insider trades.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2022

Benzinga

A young crypto billionaire's political agenda goes well beyond pandemic preparedness

In May, an eccentric 30-year-old cryptocurrency billionaire named Sam Bankman-Fried made a startling proclamation. In a podcast interview, Bankman-Fried said he would spend as much as $1 billion of his estimated $12.8-billion fortune on American politics by the 2024 election, joining the ranks of megadonors such as George Soros and…

Los Angeles Times

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Check Out What Whales Are Doing With CME

A whale with a lot of money to spend has taken a noticeably bullish stance on CME Group. Looking at options history for CME Group (NASDAQ:CME) we detected 12 strange trades.

Benzinga

Looking Into CME Group's Recent Short Interest

CME Group's (NASDAQ:CME) short percent of float has risen 14.81% since its last report. The company recently reported that it has 3.27 million shares sold short, which is 0.93% of all regular shares that are available for trading.

Benzinga

Here's How Much You Would Have Made Owning CME Group Stock In The Last 10 Years

CME Group (NASDAQ:CME) has outperformed the market over the past 10 years by 3.58% on an annualized basis producing an average annual return of 14.53%. Currently, CME Group has a market capitalization of $75.33 billion.

Benzinga

How Is The Market Feeling About CME Group?

CME Group's (NASDAQ:CME) short percent of float has fallen 18.92% since its last report. The company recently reported that it has 3.24 million shares sold short, which is 0.9% of all regular shares that are available for trading.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

$100 Invested In This Stock 10 Years Ago Would Be Worth $400 Today

CME Group (NASDAQ:CME) has outperformed the market over the past 10 years by 2.55% on an annualized basis producing an average annual return of 13.86%. Currently, CME Group has a market capitalization of $71.85 billion.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 10, 2022

Benzinga

12 Analysts Have This to Say About CME Group

Over the past 3 months, 12 analysts have published their opinion on CME Group (NASDAQ:CME) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Death Cross Looms Over CME Group Investors

If history is any guide, there may be trouble ahead for shares of CME Group (NASDAQ:CME). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Chicago Sun-Times

First futures market for health care planned in Chicago

A group is seeking regulatory approval for the Intelligent Medicine Exchange, which could help participants hedge risks from rising medical costs.

Benzinga

$100 Invested In CME Group 10 Years Ago Would Be Worth This Much

CME Group (NASDAQ:CME) has outperformed the market over the past 10 years by 2.35% on an annualized basis producing an average annual return of 14.45%. Currently, CME Group has a market capitalization of $71.41 billion.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2022

Upgrades Credit Suisse upgraded the previous rating for Molecular Partners AG (NASDAQ:MOLN) from Underperform to Neutral. NoneAt the moment, the stock has a 52-week-high of $32.04 and a 52-week-low of $5.92. Molecular Partners closed at $6.88 at the end of the last trading period.

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.